131 related articles for article (PubMed ID: 4374069)
1. Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis.
Goldstein M; Anagnoste B; Battista AF; Miyamoto T; Fuxe K
Adv Neurol; 1974; 5():79-85. PubMed ID: 4374069
[No Abstract] [Full Text] [Related]
2. Effect of dibutyryl cyclic adenosine monophosphate on 14C-dopamine biosynthesis in rat brain striatal slices.
Anagnoste B; Shirron C; Friedman E; Goldstein M
J Pharmacol Exp Ther; 1974 Dec; 191(3):370-6. PubMed ID: 4154377
[No Abstract] [Full Text] [Related]
3. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
[TBL] [Abstract][Full Text] [Related]
4. What to do when Sinemet fails: Part one.
Klawans HL
Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692
[No Abstract] [Full Text] [Related]
5. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
Raiteri M; Cerrito F; Casazza G; Levi G
Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
[No Abstract] [Full Text] [Related]
7. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
Facca A; Sanchez-Ramos J
Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153
[No Abstract] [Full Text] [Related]
8. Levodopa can worsen tremor associated with dystonia.
Hensman DJ; Bain PG
Mov Disord; 2006 Oct; 21(10):1778-80. PubMed ID: 16856131
[TBL] [Abstract][Full Text] [Related]
9. Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
Dentresangle C; Veyre L; Le Bars D; Pierre C; Lavenne F; Pollak P; Guerin J; Froment JC; Brousolle E
Mov Disord; 1999 Nov; 14(6):1025-30. PubMed ID: 10584682
[No Abstract] [Full Text] [Related]
10. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Parkinson's disease.
Lieberman A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
[TBL] [Abstract][Full Text] [Related]
12. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
Puri SK; Reddy C; Lal H
Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
[No Abstract] [Full Text] [Related]
13. Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices.
Uretsky NJ; Snodgrass SR
J Pharmacol Exp Ther; 1977 Sep; 202(3):565-80. PubMed ID: 197227
[No Abstract] [Full Text] [Related]
14. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
Agnati LF; Leo G; Vergoni AV; MartÃnez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
[TBL] [Abstract][Full Text] [Related]
15. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
Iversen LL; Horn AS; Miller RJ
Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
[No Abstract] [Full Text] [Related]
16. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
Sethy VH; VAN Woert MH
Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
[No Abstract] [Full Text] [Related]
17. Skin rash associated with Sinemet 25/100.
Goetz CG
N Engl J Med; 1983 Dec; 309(22):1387-8. PubMed ID: 6226874
[No Abstract] [Full Text] [Related]
18. The effect of trivastal, haloperidol and dibutyryl cyclic AMP on (14C)dopamine synthesis in rat striatum.
Goldstein M; Anagnoste B; Shirron C
J Pharm Pharmacol; 1973 Apr; 25(4):348-51. PubMed ID: 4146696
[No Abstract] [Full Text] [Related]
19. Levodopa in pregnancy.
von Graevenitz KS; Shulman LM; Revell SP
Mov Disord; 1996 Jan; 11(1):115-6. PubMed ID: 8771087
[No Abstract] [Full Text] [Related]
20. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa R; Koller WC
Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
